StocksPenumbra IncPEN

PEN

Penumbra Inc

272.03 -0.03 (-0.01%)
Delayed Prices By NASDAQ, in USD Market Closed
Trade
S
270.84
B
272.21

Overview

Prev Close272.03
Day's Range265.46 - 274.83
52 Week Range152.41 - 312.19
Average Volume (3m)451.43K
1-Year Return69.40%
Beta0.9154
Market Cap9.92B
P/E Ratio817.13
Revenue560.41M
EPS-0.4447
Dividend (Yield)0 (0%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.728/10/202008/01/202123/03/2021175.00200.00225.00250.00275.00300.00
Chart times in UTC
Industry Medical Specialties
CEO Adam Elsesser
Employees 3,300

FINANCIAL SUMMARY

For the quarter ended 30/9/2020, Penumbra Inc's revenues increased by 43.73% and amounted to 151.08M. Net income increased by 23.45% to -9.88M. Net assets decreased by 0.55% to 619.71M and EPS increased from -0.34 to -0.24.
PEN's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
60.20%
Net Profit Margin
2.91%
Operating Margin
-6.50%
Return On Investment
2.95%
12/19
03/20
06/20
09/20
Total Revenue
145.26M
137.33M
105.11M
151.08M
Gross Profit
97.93M
88.01M
64.74M
90.72M
Operating Income
10.51M
610K
-15.15M
-20.16M
Net Income
9.3M
888K
-12.9M
-9.88M